Revised intimation of the Earnings Call on the unaudited Financial results of the Company for the quarter ended June 30, 2026

Ref: 29/SE/LC/2026-27 Date: August 05, 2026 Scrip Code BSE: 544122 NSE: ENTERO ISIN: INE010601016 Head, Listing Compliance Department Head, Listing Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Dalal Street, Exchange Plaza, Plot No. C/1. G Block, Mumbai - 400 001. Bandra -Kurla Complex, Bandra (East), Mumbai- 400051 Dear Sir/Madam, Subject: Revised intimation of the Earnings Call on the Unaudited Financial Results of the Company for the Quarter Ended June 30, 2026 This in further to our intimation letter dated August 04, 2026, bearing reference no. 28/SE/LC/2026-27 and pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose revised intimation regarding the Earnings Call with analysts and investors. The revision pertains solely to the meeting link and there are no other changes to the schedule or other details of the Earnings Call as communicated in our earlier intimation. Yours faithfully, For Entero Healthcare Solutions Limited Sanu Kapoor Vice President- Group General Counsel, Company Secretary & Compliance Officer Encl. Earnings Call Invitation Monarch Networth Cordially Invites you to a Conference Call With The Management of 10th August 2026, 12.00 Noon (IST) Monday Agenda: Discussion on Q1FY27 Earnings update Click Here EXPRESS JOIN WITH DIAMOND PASS Company Management Mr. Prabhat Agrawal Mr. Prem Sethi Dr. Balakrishnan Managing Director & Whole Time Director & Natesan Kaushik Group CFO Country International Toll Free Universal Dial -in Numbers Hong Kong +800 964 448 International Primary Number: +91 22 6280 1455 Singapore +800 101 2045 Numbers UK +80 810 11573 Alternate Number: +91 22 7115 8828 USA +186 674 62133 RSVP: Mr. Rahul Dani EMAIL: rahul.dani@mnclgroup.com